Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Asian Pac J Allergy Immunol ; 1994 Jun; 12(1): 7-13
Article in English | IMSEAR | ID: sea-36661

ABSTRACT

Eleven moderate-to-severe asthmatic children 5-11 years of age who were in stable condition were given (randomly, double-blind) nebulized salbutamol sulfate (Asmasal) inhalation therapy at doses of 0.1, 0.2 and 0.3 mg/kg body weight on separated days. All three doses of nebulized solution resulted in clinical improvement and improvement of lung function (FEV1, FVC, PEFR and FEF25-75%). A dose of 0.3 mg/kg produced greatest improvement and longest duration of improvement in FEV1 and PEFR, but the change was statistically significant only in PEFR at 60 minutes (p < 0.05). Five children experienced mild tremors. There were no significant changes in heart rate or blood pressure at any dose. It is concluded that a nebulized solution of salbutamol sulfate at a dose of 0.1-0.3 mg/kg is useful for treatment of asthma in Thai children, with very mild side effects.


Subject(s)
Administration, Inhalation , Albuterol/administration & dosage , Asthma/drug therapy , Child , Cross-Over Studies , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Pulmonary Ventilation/drug effects , Thailand
2.
Article in English | IMSEAR | ID: sea-138087

ABSTRACT

Twenty-one obese children who attended a 4-week summer camping in Siriraj Hospital were evaluated for their lung function before and after camping. Twelve out of 21 children (57%) were found to have restrictive lung before camping. Of these 12 children, 6 of them (50%) had improvement of lung function, whereas 4 out of those with abnormal lung function (33%) had normal lung function after campings.

3.
Asian Pac J Allergy Immunol ; 1992 Dec; 10(2): 111-5
Article in English | IMSEAR | ID: sea-37006

ABSTRACT

The ice cube test performed in 24 children (6 cold urticaria, 6 healthy, 6 allergic and 6 chronic urticaria) showed that a 3 and 5-minute ice cube test was the appropriate time for the diagnosis of cold urticaria without false positive results. If the test was prolonged to 10 and 20 minutes, 17% and 33% respectively showed false positive results in chronic urticaria other than cold urticaria patients. After four weeks of cyproheptadine therapy, the ice cube test showed only 17% positive at 3 minutes and 33% at 5 minutes. When the ice cube test was performed for 10 and 20 minutes, 67% showed positive results. In conclusion, the ice cube test should be performed for 3 to 5 minutes to diagnose cold urticaria in children. The time should be increased to 10 or 20 minutes if the test shows negative results at 3 to 5 minutes after antihistamine therapy.


Subject(s)
Child , Child, Preschool , Chronic Disease , Cold Temperature/adverse effects , Cyproheptadine/therapeutic use , False Positive Reactions , Female , Humans , Ice , Male , Predictive Value of Tests , Sensitivity and Specificity , Skin Tests/methods , Urticaria/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL